UnitedHealth Group (UNH) Receives Daily Media Sentiment Rating of 0.20

Press coverage about UnitedHealth Group (NYSE:UNH) has trended somewhat positive on Wednesday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UnitedHealth Group earned a news sentiment score of 0.20 on Accern’s scale. Accern also gave press coverage about the healthcare conglomerate an impact score of 46.2357174377554 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Here are some of the media headlines that may have impacted Accern’s analysis:

Shares of UnitedHealth Group (NYSE:UNH) traded down $1.68 on Wednesday, reaching $224.20. The company’s stock had a trading volume of 2,311,609 shares, compared to its average volume of 2,702,657. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group has a one year low of $156.09 and a one year high of $231.77. The firm has a market capitalization of $216,770.00, a price-to-earnings ratio of 25.48, a P/E/G ratio of 1.57 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the company earned $2.17 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. analysts anticipate that UnitedHealth Group will post 9.99 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.34%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s payout ratio is currently 34.09%.

Several research firms recently commented on UNH. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Oppenheimer raised their target price on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a report on Wednesday, October 18th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $208.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 17th. Morgan Stanley raised their target price on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Finally, Leerink Swann reaffirmed a “buy” rating and set a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Three analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $226.74.

In other news, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,630 shares of company stock worth $7,669,416. 0.89% of the stock is owned by corporate insiders.

WARNING: “UnitedHealth Group (UNH) Receives Daily Media Sentiment Rating of 0.20” was originally posted by Markets Daily and is owned by of Markets Daily. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at https://www.themarketsdaily.com/2018/01/11/unitedhealth-group-unh-receives-daily-media-sentiment-rating-of-0-20.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply